Sikiric P, Seiwerth S, Rucman R, Kolenc D, Vuletic LB, Drmic D, Grgic T, Strbe S, Zukanovic G, Crvenkovic D, Madzarac G, Rukavina I, Sucic M, Baric M, Starcevic N, Krstonijevic Z, Bencic ML, Filipcic I, Rokotov DS, Vlainic J
Last reviewed: May 16, 2026 Last updated: May 16, 2026 Written by: Jay Hastings , CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
TB-500: Common range: 25 mg weekly, split into 2 doses
This peptide fragment was developed in the late 1990s by Australian firm Metabolic Pharmaceuticals [1]
Why Batch Traceability Matters Batch traceability helps ensure that the research material corresponds with the correct analytical records